VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 106 filers reported holding VENTYX BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,658,665 | +5.9% | 422,075 | 0.0% | 1.61% | +68.0% |
| Q2 2023 | $13,844,060 | -31.4% | 422,075 | -29.9% | 0.96% | -31.7% |
| Q1 2023 | $20,169,513 | +47096.7% | 602,075 | -53.8% | 1.40% | -71.5% |
| Q4 2022 | $42,735 | -99.9% | 1,303,294 | -3.9% | 4.92% | -5.9% |
| Q3 2022 | $47,333,000 | +101.4% | 1,355,861 | -29.4% | 5.23% | +121.4% |
| Q2 2022 | $23,503,000 | -9.9% | 1,921,726 | 0.0% | 2.36% | +31.4% |
| Q1 2022 | $26,078,000 | -26.7% | 1,921,726 | +7.3% | 1.80% | -16.3% |
| Q4 2021 | $35,575,000 | – | 1,791,275 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |